Astellas Pharma, Japan
New data from Astellas Pharma, Japan, studies illuminate research
Published in Lab Business Week, February 4th, 2007
This trend article about Astellas Pharma, Japan, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Fresh data on metabolism are presented in the report "Elucidation of the effects of the CYP1A2 deficiency polymorphism in the metabolism of 4-cyclohexyl-1-ethyl-7-methylpyrido[2,3-d]pyrimidine-2-(1h)-one (YM-64227), a phosphodiesterase type 4 inhibitor, and its metabolites in dogs. The canine CYP1A2 1117 C>T single nucleotide polymorphism is responsible for a substantial portion of the interindividual variability seen in the pharmacokinetics of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-02-04)
More Articles from Lab Business Week
- Biomedical Engineering
Research from Dr. Reddy's Laboratories Ltd. in the area of biomedical engineering published - Biotechnology
Research from Michael Smith Laboratories broadens understanding of biotechnology - Business Update
Charles River Laboratories' Endosafe-Pts completes journey to International Space Station - Generic Drugs
Mylan's levothyroxine sodium tablets USP approved as generic equivalent to Levothroid - Genetics & Genomics
Research data from Jackson Laboratory update understanding of genetics & genomics - Immunology
Research on immunology discussed by scientists at EIC Laboratories, Inc. - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
